Pearlstone D B, Feig B W, Mansfield P F
Department of Surgical Oncology, University of Texas M.D. Anderson Cancer Center, Houston 77030, USA.
Semin Surg Oncol. 1999 Jun;16(4):307-12. doi: 10.1002/(sici)1098-2388(199906)16:4<307::aid-ssu5>3.0.co;2-5.
Reports of recurrent malignant disease developing at laparoscopic port sites has created considerable controversy among surgeons. Many have implicated the technique of laparoscopy as a cause of metastases and this has led to condemnation of laparoscopy in malignant disease by many surgeons. A review of the case reports, as well as animal studies, reveals the problem to be considerably more complex. Based on experimental models, reported cases, and our experience at the University of Texas M. D. Anderson Cancer Center, we have arrived at some substantive conclusions regarding this phenomenon. Port site recurrences (PSRs) after laparoscopy for malignant disease can occur as the only site of recurrence, but this is an extremely rare event, and the incidence does not appear to be significantly different from the development of wound recurrences after open laparotomy for malignancy. It is likely that port site recurrences reflect the underlying biology of the malignant disease, rather than an effect of the technique of laparoscopy.
腹腔镜手术穿刺部位出现复发性恶性疾病的报告在外科医生中引发了相当大的争议。许多人认为腹腔镜技术是转移的一个原因,这导致许多外科医生谴责在恶性疾病中使用腹腔镜技术。对病例报告以及动物研究的回顾表明,问题要复杂得多。基于实验模型、报告的病例以及我们在德克萨斯大学MD安德森癌症中心的经验,我们对这一现象得出了一些实质性结论。腹腔镜手术后恶性疾病的穿刺部位复发(PSRs)可能作为唯一的复发部位出现,但这是极其罕见的情况,而且其发生率似乎与恶性肿瘤开腹手术后伤口复发的发生率没有显著差异。穿刺部位复发很可能反映了恶性疾病的潜在生物学特性,而非腹腔镜技术的影响。